House Health Care - 2026-04-09 - 9:00AM
Committee · April 9, 2026
Discussion of S154, a proposed study of biomarker testing and its potential cost and defrayal implications; Deputy Commissioner Mary Block (DFR) urged the study be broadened and warned of potential state costs if CMS requires defrayal for mandates enacted since 2011.
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.
No transcript available.
No outline available for this source.
No related articles available for this source.
No highlights available for this source.
No claims available for this source.
No actions available for this source.
No topics available for this source.
No clarifying details available for this source.
No discussions available for this source.
No community relevance data available for this source.
No funding sources available for this source.
No speakers available for this source.
No transcript available for this source.